SBI Healthcare Opportunities Fund
SBI Mutual Fund · FM: Tanmaya Desai · INF200K01UP2 · Direct
NAV ₹605.75 AUM ₹5398 Cr as of 22 Sep 2026
Portfolio as of Jul 2026 · Last Update: 16-Aug-2026 05:00 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.9% | +0.4% | +8.4% | +26.0% | +21.5% | +25.0% | +18.4% | 13/234 | 1.03% |
Equity allocation
98.31%
Non-equity allocation (combined)
1.69%
All Equity Holdings (33) as of Jul 2026
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 686.7 | 12.72% | — |
| 2 | Divi's Laboratories Ltd. | 402.8 | 7.46% | — |
| 3 | Acutaas Chemicals Ltd. | 279.4 | 5.17% | — |
| 4 | Cipla Ltd. | 274.0 | 5.07% | — |
| 5 | Apollo Hospitals Enterprise Ltd. | 268.7 | 4.98% | — |
| 6 | Torrent Pharmaceuticals Ltd. | 256.1 | 4.74% | — |
| 7 | Max Healthcare Institute Ltd. | 247.2 | 4.58% | — |
| 8 | Laurus Labs Ltd. | 217.9 | 4.04% | — |
| 9 | Aurobindo Pharma Ltd. | 208.6 | 3.86% | — |
| 10 | Aster DM Quality Care Ltd. | 197.3 | 3.65% | — |
| 11 | Biocon Ltd. | 159.6 | 2.96% | — |
| 12 | Jupiter Life Line Hospitals Ltd. | 155.4 | 2.88% | — |
| 13 | Anthem Biosciences Ltd. | 152.1 | 2.82% | — |
| 14 | Gland Pharma Ltd. | 150.2 | 2.78% | — |
| 15 | Fortis Healthcare Ltd. | 141.8 | 2.63% | — |
| 16 | Sai Life Sciences Ltd. | 131.5 | 2.44% | — |
| 17 | Aether Industries Ltd. | 123.2 | 2.28% | — |
| 18 | Sudeep Pharma Ltd. | 119.8 | 2.22% | — |
| 19 | Polymedicure Ltd. | 108.9 | 2.02% | — |
| 20 | Krishna Institute of Medical Sciences Ltd. | 107.1 | 1.98% | — |
| 21 | Ajanta Pharma Ltd. | 104.0 | 1.93% | — |
| 22 | Concord Biotech Ltd. | 102.3 | 1.89% | — |
| 23 | Mankind Pharma Ltd. | 98.8 | 1.83% | — |
| 24 | Lupin Ltd. | 96.6 | 1.79% | — |
| 25 | Cohance Lifesciences Ltd. | 93.5 | 1.73% | — |
| 26 | Global Health Ltd. | 90.0 | 1.67% | — |
| 27 | Nephrocare Health Service Pvt. Ltd. | 65.0 | 1.20% | — |
| 28 | Dr. Lal Path labs Ltd. | 57.2 | 1.06% | — |
| 29 | Abbott India Ltd. | 55.6 | 1.03% | — |
| 30 | Syngene International Ltd. | 51.6 | 0.96% | — |
| 31 | Rainbow Children's Medicare Ltd. | 45.8 | 0.85% | — |
| 32 | Healthcare Global Enterprises Ltd. | 39.5 | 0.73% | — |
| 33 | Gufic Biosciences Ltd. | 19.5 | 0.36% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.